Table 2.
The relationship between patients’ clinical–pathological characteristics and cytoplasmic ASPP1 expression in CRC.
| Parameters | No. | Cytosol low | Cytosol high | P value |
|---|---|---|---|---|
| Age (years) | ||||
| ≤60 | 32 | 15 | 17 | 0.54 |
| >60 | 54 | 29 | 25 | |
| Gender | ||||
| Male | 48 | 21 | 27 | 0.193 |
| Female | 38 | 22 | 16 | |
| Lymph node | ||||
| N0 | 48 | 22 | 26 | 0.299 |
| N1 + N2 | 33 | 19 | 14 | |
| Clinical stage | ||||
| I + II | 42 | 18 | 24 | 0.108 |
| III + IV | 36 | 22 | 14 | |
| Pathological staging | ||||
| I + II | 61 | 31 | 30 | 0.812 |
| III | 25 | 12 | 13 | |
| Distant metastasis | ||||
| M0 | 83 | 42 | 41 | 0.584 |
| M1 | 3 | 2 | 1 | |
P-values were generated by Chi-square test or Fisher’s exact test.
P < 0.05 was considered as statistically significant.